Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs midazolam for sedation during noninvasive ventilation in acute respiratory failure
ChiCTR2100043930Phase 4Recruiting
- Sponsor
- Renmin Hospital of Wuhan University
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam in acute respiratory decompensation (2 arms), sponsored by Renmin Hospital of Wuhan University. Primary endpoint: RSAS score. Started Apr 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
acute respiratory decompensation
Beyond the preview
Go deeper on ChiCTR2100043930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043930.